The clinical manifestations of COVID-19 are widely variable and may involve several districts. Although the clinical course is mostly characterized by respiratory involvement, up to 30% of hospitalized patients have evidence of myocardial injury due to acute coronary syndrome, cardiac arrhythmias, myocarditis, and cardiogenic shock. In particular, myocarditis is a well-recognized severe complication of COVID-19 and is associated with fulminant cardiogenic shock and sudden cardiac death. In this article, the authors aim to present a comprehensive review about COVID-19-related myocarditis, including clinical characteristics, diagnostic workup, and management.

Prevalence and clinical Implications of COVID-19 myocarditis / Chimenti, C.; Magnocavallo, M.; Ballatore, F.; Bernardini, F.; Alfarano, M.; Della Rocca, D. G.; Severino, P.; Lavalle, C.; Francesco, F.; Frustaci, A.. - In: CARDIAC ELECTROPHYSIOLOGY CLINICS. - ISSN 1877-9182. - 14:1(2022), pp. 53-62. [10.1016/j.ccep.2021.11.001]

Prevalence and clinical Implications of COVID-19 myocarditis

Chimenti C.
;
Magnocavallo M.;Ballatore F.;Bernardini F.;Alfarano M.;Severino P.;Lavalle C.;Frustaci A.
2022

Abstract

The clinical manifestations of COVID-19 are widely variable and may involve several districts. Although the clinical course is mostly characterized by respiratory involvement, up to 30% of hospitalized patients have evidence of myocardial injury due to acute coronary syndrome, cardiac arrhythmias, myocarditis, and cardiogenic shock. In particular, myocarditis is a well-recognized severe complication of COVID-19 and is associated with fulminant cardiogenic shock and sudden cardiac death. In this article, the authors aim to present a comprehensive review about COVID-19-related myocarditis, including clinical characteristics, diagnostic workup, and management.
2022
arrhythmias; COVID-19; myocardial damage; myocarditis; SARS-CoV-2; vascular damage; cardiac; humans; prevalence;
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Prevalence and clinical Implications of COVID-19 myocarditis / Chimenti, C.; Magnocavallo, M.; Ballatore, F.; Bernardini, F.; Alfarano, M.; Della Rocca, D. G.; Severino, P.; Lavalle, C.; Francesco, F.; Frustaci, A.. - In: CARDIAC ELECTROPHYSIOLOGY CLINICS. - ISSN 1877-9182. - 14:1(2022), pp. 53-62. [10.1016/j.ccep.2021.11.001]
File allegati a questo prodotto
File Dimensione Formato  
Chimenti_Prevalence_2022.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.96 MB
Formato Adobe PDF
1.96 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1634466
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 18
  • ???jsp.display-item.citation.isi??? ND
social impact